• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

New gene variants linked with Alzheimer Disease in African Americans

bys25qthea
April 9, 2013
in Chronic Disease, Neurology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD. PET scans of healthy vs. diseased brains

1. ABCA7 variants are associated with an increased risk of Alzheimer Disease in African Americans, more so than in non-Hispanic whites.

2. ABCA7 encodes an ATP binding cassette transporter, which interacts with apolipoproteins and thus affects lipid metabolism.

Study Rundown: In this retrospective meta-analysis, the researchers observed an association between a single-nucleotide polymorphism (SNP) in the ABCA7 region and risk of Alzheimer disease in African Americans. Not only did this finding reach genome-wide significance, but its effect size was relatively large as well. This study was unique because it specifically targeted African Americans, and it is the largest of its kind to study Alzheimer disease in this population.

The results are particularly noteworthy given a plausible mechianism, as ABCA7 is involved in lipid metabolism. This knowledge, in conjunction with the role of APOE genes, may help better elucidate the pathophysiology of this complex disease. In the future, targeted genetic screening may be used for disease risk assessments. In addition, the fact that some SNPs continue to be identified as associated with Alzheimer disease, regardless of the population being studied, contributes to the idea that they are important for disease susceptibility. The limitations of this study are few, but important given that Alzheimer is a complex disease with both heritable and environmental components. This study does not assess the contribution of other influences, such as multiple rare variants or structural variants, as it only identified susceptibility loci. As an inherent limitation, the identified loci may not be the ones causing disease, but rather may be in linkage disequilibrium with others that are and cannot be identified yet.

Click to read the study, published today in JAMA

Click to read an accompanying editorial in JAMA

RELATED REPORTS

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

2 Minute Medicine Rewind June 13, 2022 

2 Minute Medicine Rewind June 6, 2022

In-Depth [retrospective, case-control meta-analysis]: The study included a total of 5896 African Americans aged 60 or older, 1,968 of whom were case participants and 3,928 of whom were control participants. Genome wide analyses were conducted in order to identify associations between SNPs, which were either genotyped or imputed, and Alzheimer disease. Additionally, directed studies were conducted to look for similar associations with loci previously reported in the literature. A novel finding from this study is an association between Alzheimer disease and a SNP in ABCA7, which achieved genome-wide significance (odds ratio (OR) 1.79, p = 2.2 x 10-9). Furthermore, the effect size of the aforementioned gene is similar to that of the well known APOE OR 2.31, p = 5.5 x 10-47). Finally, four other susceptibility loci (CR1, BIN1, EPHA1, CD33), which were previously described in the literature for non-Hispanic whites, were shown again to be significantly associated with Alzheimer disease.

By Anne Marie Walters and Rif Rahman

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

 

Tags: ABCA7alzheimergeriatrics
Previous Post

TV associated with higher BMI in teens

Next Post

Metagenomics: A new method of identifying bacterial outbreaks

RelatedReports

Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease

June 17, 2022
Long-term outcomes for off-pump and on-pump CABG are similar
Weekly Rewinds

2 Minute Medicine Rewind June 13, 2022 

June 20, 2022
Weekly Rewinds

2 Minute Medicine Rewind June 6, 2022

June 6, 2022
Genetic risk assessment for Alzheimer’s disease does not increase anxiety, depression or stress
Chronic Disease

Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms

May 26, 2022
Next Post
Metagenomics: A new method of identifying bacterial outbreaks

Metagenomics: A new method of identifying bacterial outbreaks

Science: tried and true? [Perspective]

Science: tried and true? [Perspective]

Functional MRI map for physical pain identified

Functional MRI map for physical pain identified

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Fazirsiran reduces Z-AAT protein production in alpha1-antitrypsin deficiency
  • Arterial chemoembolization improves survival in non-resectable hepatocellular carcinoma [Classics Series]
  • #VisualAbstract: Anti-tau antibody Semorinemab not shown to slow clinical progression of Alzheimer’s disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.